Colorectal Cancer Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by iOMEDICO AG
Sponsor:
Collaborators:
Arbeitskreis Klinische Studien
Arbeitsgemeinschaft Internistische Onkologie (AIO)
Information provided by (Responsible Party):
iOMEDICO AG
ClinicalTrials.gov Identifier:
NCT00910819
First received: May 28, 2009
Last updated: March 14, 2014
Last verified: March 2014
  Purpose

The purpose of this registry is to record information on the antineoplastic treatment of colorectal cancer in Germany. The registry will follow up patients for five years. It will identify common therapeutic sequences and changes in the treatment of the disease. The impact of nutrition (CoNut) and physical activity (CoNut) on the course of the adjuvant disease will be examined, as well as long-term effects of adjuvant treatment (CoTox) and the final phase of the palliative process (CoLife). Based on the available data a prognostic score will be developed.


Condition Intervention
Colorectal Cancer
Other: non-interventional

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective and Retrospective Observation of the Adjuvant and Palliative Treatment Strategies in the Therapy of Colorectal Cancer in Germany

Resource links provided by NLM:


Further study details as provided by iOMEDICO AG:

Primary Outcome Measures:
  • Course of Antineoplastic Treatment [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 6500
Study Start Date: September 2006
Estimated Study Completion Date: March 2020
Estimated Primary Completion Date: March 2020 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Colorectal cancer patients undergoing antineoplastic treatment.

Criteria

Inclusion Criteria:

  • Colorectal cancer
  • 18 years and older
  • Antineoplastic treatment

Exclusion Criteria:

  • No colorectal cancer
  • Below 18 years
  • No antineoplastic treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00910819

Contacts
Contact: Stefanie Kopfmann +49 761 15242 - 0 info@iomedico.com
Contact: Holger Hartmann, PhD +49 761 15242 - 0 info@iomedico.com

Locations
Germany
iOMEDICO AG Recruiting
Freiburg, BW, Germany, 79108
Sponsors and Collaborators
iOMEDICO AG
Arbeitskreis Klinische Studien
Arbeitsgemeinschaft Internistische Onkologie (AIO)
Investigators
Study Chair: Roland Schnell, MD
  More Information

No publications provided

Responsible Party: iOMEDICO AG
ClinicalTrials.gov Identifier: NCT00910819     History of Changes
Other Study ID Numbers: IOM TKK
Study First Received: May 28, 2009
Last Updated: March 14, 2014
Health Authority: Germany: Ethics Commission

Keywords provided by iOMEDICO AG:
Colorectal Cancer
Advanced Colorectal Cancer
Epidemiology
Registry
Health Services Research
Germany
Palliative Care
Palliative Treatment
Adjuvant Drug Therapy
Nutrition Assessment
Physical Activity

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on August 19, 2014